Geode Capital Management
MEDS icon

Geode Capital Management’s DataMeds AI MEDS Stock Holding History

Geode Capital Management’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$60.7K Buy
19,137
+6,670
+54% +$16.3K ﹤0.01% 4162
2026
Q2 		$38.6K Sell
12,467
-1,748
-12% -$8.6K ﹤0.01% 4288
2026
Q1 		$68.5K Buy
14,215
+4,467
+46% +$61.3K ﹤0.01% 4235
2025
Q4 		$195K Buy
9,748
+4,364
+81% +$128K ﹤0.01% 3914
2025
Q3 		$239K Buy
+5,384
New +$284K ﹤0.01% 3864

Other funds holding MEDS

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Geode Capital Management's MEDS Position: Q3 2026 in Review

Geode Capital Management increased its DataMeds AI (MEDS) stake by 54% in Q3 2026, buying an estimated $16.3K and bringing the position to 19,137 shares worth $60.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4162.

Geode Capital Management first reported a position in MEDS in Q3 2025 and has held it in 5 quarters since. The position peaked at $239K in Q3 2025. 6 funds tracked by Wall St. Rank hold MEDS as of Q3 2026.

  • Geode Capital Management held 19,137 shares of DataMeds AI worth $60.7K as of Q3 2026.
  • Geode Capital Management bought 6,670 DataMeds AI shares in Q3 2026, an estimated $16.3K.
  • DataMeds AI made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4162 holding.
  • Geode Capital Management first reported a position in DataMeds AI in Q3 2025 and has held it in 5 quarters since.
  • Geode Capital Management's DataMeds AI position peaked at $239K in Q3 2025.
  • 6 funds tracked by Wall St. Rank held DataMeds AI as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.